Triumvira Immunologics

Triumvira Immunologics, Inc. is a biotechnology company located in Austin, Texas. Founded in 2015, the company currently employs 56 people. Triumvira Immunologics is focused on developing a proprietary T cell Antigen Coupler (TAC) technology. This technology is intended to be a safer and more effective treatment for cancer than current methods such as chimeric antigen receptor (CAR) and engineered T cell receptor (TCR) therapies. The company seeks to provide new hope for patients with life-threatening diseases through its research and development efforts. Triumvira Immunologics brings together a diverse team of professionals with expertise in immunobiology, drug development, fundraising, commercialization, and finance. The company's team has extensive experience working in both large pharmaceutical companies and smaller biotechnology firms, as well as in academia. For more information about career opportunities at Triumvira Immunologics, please visit their Careers webpage at triumvira.com/contact-us/careers/.